Proteomic profiling of cerebrospinal fluid in parkinsonian disorders
Radu Constantinescu(Sahlgrenska University Hospital), Henrik Zetterberg(University of Wisconsin–Madison), Henrik Anckarsäter(Lund University), Kaj Blennow(Sahlgrenska University Hospital), Niklas Mattsson(Malmö University), Susann Li(University of Gothenburg), Ulf Andréasson(Sahlgrenska University Hospital), Rolf Anckarsäter(Kungälvs Sjukhus), Carsten Wikkelsø(University of Gothenburg), Ulla Rüetschi(University of Gothenburg), Björn Holmberg(Sahlgrenska University Hospital), Vladimir N. Podust, Lars Rosengren(Sahlgrenska University Hospital)
Cited by 43
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k